Novonesis A S (NVZMF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novonesis A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.900 Ladies and gentlemen, welcome to the NovoNazis Q1 2025 conference call. 00:00:05.900 -- 00:00:08.765 I am Healy, the chorus call operator. 00:00:08.765 -- 00:00:13.432 I would like to remind you that all participants will be in listen-only mode and the 00:00:13.432 -- 00:00:19.321 conference is being recorded. The presentation will be followed by a Q&A session. 00:00:19.321 -- 00:00:25.170 You can register for questions at any time by pressing star and one on your telephone. 00:00:25.170 -- 00:00:28.938 For operator assistance, please press star and zero. 00:00:28.938 -- 00:00:33.488 The conference must not be recorded for publication or broadcast. 00:00:33.488 -- 00:00:38.679 At this time, it's my pleasure to hand over to Tobias Cornelius Björklund, head of investor 00:00:38.679 -- 00:00:41.847 relations. Please go ahead. 00:00:41.847 -- 00:00:46.133 Thank you very much, operator, and welcome everyone to the NovoNesis conference call 00:00:46.133 -- 00:00:50.619 for the first quarter of 2025. My name is Tobias Björklund, and as I said, I'm heading 00:00:50.619 -- 00:00:54.024 up our investor relation activities here at NovoNesis. 00:00:54.024 -- 00:00:59.191 In this call, our CEO, Esther Baggett, and our CFO, Rainer Lehmann, will review our performance 00:00:59.191 -- 00:01:02.733 for the year, as well as the outlook for 2025. 00:01:02.756 -- 00:01:08.243 Also attending today's calls are Amy Byrick, EVP of Human Health BioSolutions, 00:01:08.243 -- 00:01:13.277 Tina Feiner, EVP of Planetary Health Biosolutions, and Klaus-Krone Fuglsang, Chief Scientific 00:01:13.277 -- 00:01:18.160 Officer. The conference call will take about 45 minutes, including Q&A. 00:01:18.160 -- 00:01:22.927 Please change to the next slide. And this is, as u...